Reported Earnings • Mar 29
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: EPS: UK£0.003 (up from UK£0.014 loss in FY 2024). Revenue: UK£38.0m (down 3.4% from FY 2024). Net income: UK£1.16m (up UK£6.29m from FY 2024). Profit margin: 3.0% (up from net loss in FY 2024). The move to profitability was driven by lower expenses. Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) also missed analyst estimates by 30%. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Healthcare Services industry in Australia. Over the last 3 years on average, earnings per share has increased by 77% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth. Announcement • Mar 06
Doctor Care Anywhere Group PLC, Annual General Meeting, Apr 28, 2026 Doctor Care Anywhere Group PLC, Annual General Meeting, Apr 28, 2026. New Risk • Feb 28
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.7x net interest cover). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (AU$67.9m market cap, or US$48.3m). Reported Earnings • Feb 26
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: EPS: UK£0.003 (up from UK£0.014 loss in FY 2024). Revenue: UK£38.0m (down 3.4% from FY 2024). Net income: UK£1.16m (up UK£6.29m from FY 2024). Profit margin: 3.0% (up from net loss in FY 2024). The move to profitability was driven by lower expenses. Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) also missed analyst estimates by 30%. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 26% growth forecast for the Healthcare Services industry in Australia. Over the last 3 years on average, earnings per share has increased by 77% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth. Announcement • Feb 19
Doctor Care Anywhere Group PLC to Report Fiscal Year 2025 Results on Feb 25, 2026 Doctor Care Anywhere Group PLC announced that they will report fiscal year 2025 results on Feb 25, 2026 Announcement • Jan 23
Doctor Care Anywhere Group PLC to Report Q4, 2025 Results on Jan 29, 2026 Doctor Care Anywhere Group PLC announced that they will report Q4, 2025 results on Jan 29, 2026 Recent Insider Transactions • Jan 16
Independent Chairman of the Board recently bought AU$73k worth of stock On the 8th of January, John Stier bought around 500k shares on-market at roughly AU$0.15 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth AU$195k. John has been a buyer over the last 12 months, purchasing a net total of AU$270k worth in shares. New Risk • Dec 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Negative equity (-UK£89k). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Market cap is less than US$100m (AU$53.2m market cap, or US$35.7m). Announcement • Oct 20
Doctor Care Anywhere Group PLC to Report Q3, 2025 Results on Oct 29, 2025 Doctor Care Anywhere Group PLC announced that they will report Q3, 2025 results on Oct 29, 2025 Breakeven Date Change • Sep 03
Forecast breakeven date moved forward to 2025 The analyst covering Doctor Care Anywhere Group previously expected the company to break even in 2026. New forecast suggests the company will make a profit of UK£1.60m in 2025. Earnings growth of 78% is required to achieve expected profit on schedule. Reported Earnings • Aug 29
First half 2025 earnings released: EPS: UK£0.001 (vs UK£0.007 loss in 1H 2024) First half 2025 results: EPS: UK£0.001 (up from UK£0.007 loss in 1H 2024). Revenue: UK£19.2m (down 12% from 1H 2024). Net income: UK£471.0k (up UK£3.00m from 1H 2024). Profit margin: 2.4% (up from net loss in 1H 2024). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Healthcare Services industry in Australia. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth. Announcement • Jul 15
Doctor Care Anywhere Group PLC to Report Q2, 2025 Results on Jul 31, 2025 Doctor Care Anywhere Group PLC announced that they will report Q2, 2025 results on Jul 31, 2025 Reported Earnings • Apr 04
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: UK£0.014 loss per share (improved from UK£0.022 loss in FY 2023). Revenue: UK£39.3m (up 2.3% from FY 2023). Net loss: UK£5.14m (loss narrowed 37% from FY 2023). Revenue missed analyst estimates by 3.6%. Earnings per share (EPS) also missed analyst estimates by 142%. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Healthcare Services industry in Australia. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings. Announcement • Apr 02
Doctor Care Anywhere Group PLC, Annual General Meeting, Apr 30, 2025 Doctor Care Anywhere Group PLC, Annual General Meeting, Apr 30, 2025. Location: offices of crowe llp, 55 ludgate hill, london ec4m 7jw, Australia Reported Earnings • Feb 28
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: UK£0.02 loss per share (improved from UK£0.022 loss in FY 2023). Revenue: UK£39.3m (up 2.3% from FY 2023). Net loss: UK£5.14m (loss narrowed 37% from FY 2023). Revenue missed analyst estimates by 3.6%. Earnings per share (EPS) also missed analyst estimates by 142%. Revenue is forecast to grow 9.9% p.a. on average during the next 2 years, compared to a 23% growth forecast for the Healthcare Services industry in Australia. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has fallen by 38% per year, which means it is significantly lagging earnings. Announcement • Feb 06
Doctor Care Anywhere Group PLC to Report Fiscal Year 2024 Results on Feb 27, 2025 Doctor Care Anywhere Group PLC announced that they will report fiscal year 2024 results on Feb 27, 2025 Announcement • Jan 29
Doctor Care Anywhere Group PLC Appoints Sam Shah as an Additional Non-Executive Director Doctor Care Anywhere Group PLC advised of the appointment of Professor Sam Shah as an additional non-executive director with effect from 28 January 2025. Professor Shah is a public health consultant and specialist in dental public health, with expertise in epidemiology, health regulation and corporate governance. He holds both clinical and legal qualifications and co-founded East Village Clinic Group, an NHS and private healthcare services organisation. Professor Shah is Director of SAS Consultancy Services Limited (The Ivory Clinic) and EVD Group Holdings Limited (East Village Dental) and their respective subsidiaries. He is also a Non-Executive Director of the Private Healthcare Information Network, Director and advisor of Quiddity and Director of Health Data Management, NEOM. He has extensive board level knowledge across the technology, investment, and global health ecosystem; having worked with organizations across Europe, North America, Middle East and Asia. Announcement • Jan 23
Doctor Care Anywhere Group PLC to Report Q4, 2024 Results on Jan 30, 2025 Doctor Care Anywhere Group PLC announced that they will report Q4, 2024 results at 10:00 AM, AUS Eastern Standard Time on Jan 30, 2025 Board Change • Dec 25
Less than half of directors are independent There are 4 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. 2 independent directors (3 non-independent directors). Non-Executive Director David Ravech is the most experienced director on the board, commencing their role in 2015. Independent Non-Executive Director Ola Spencer was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors. Announcement • Oct 18
Doctor Care Anywhere Group PLC to Report Q3, 2024 Results on Oct 30, 2024 Doctor Care Anywhere Group PLC announced that they will report Q3, 2024 results on Oct 30, 2024 Announcement • Aug 29
Doctor Care Anywhere Group PLC Announces Ben Kent to Step Down as CEO in 2025 Doctor Care Anywhere Group PLC announced that Ben Kent to step down as CEO in 2025. Ben was appointed as interim CEO in February 2023 with a clear mandate: to steady the ship after a challenging 2022, to deliver on DCA's growth plans, and to regain the confidence of shareholders and key clients. He was appointed as a Director in March 2024. Ben has delivered on his mandate as CEO. Accordingly, Ben and the Board of DCA have agreed that this is the right time for Ben to pass the baton to a successor. While the Board is undertaking a search for a new CEO, Ben will continue in his role, either until the end of March 2025 or until a new CEO is appointed (whichever is earlier). Announcement • Apr 05
Doctor Care Anywhere Group PLC, Annual General Meeting, Apr 29, 2024 Doctor Care Anywhere Group PLC, Annual General Meeting, Apr 29, 2024, at 07:00 Coordinated Universal Time. Location: The Offices of Crowe LLP, 55 Ludgate Hill - London United Kingdom Agenda: To consider Appointment of Crowe LLP as Auditors; to consider election and re-election of Directors Dr Aleksandra Spencer; to consider election and re-election of Directors Ben Kent; to consider approval of the Remuneration Report; to consider long Term Incentive Plan; to consider company Share Option Plan; and to consider save As You Earn Scheme. Reported Earnings • Mar 01
Full year 2023 earnings released: UK£0.024 loss per share (vs UK£0.061 loss in FY 2022) Full year 2023 results: UK£0.024 loss per share (improved from UK£0.061 loss in FY 2022). Revenue: UK£38.5m (up 29% from FY 2022). Net loss: UK£8.17m (loss narrowed 63% from FY 2022). Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has fallen by 60% per year, which means it is significantly lagging earnings. Announcement • Feb 01
Doctor Care Anywhere Group PLC Announces Change of Company Secretary Doctor Care Anywhere Group PLC advised that Kevin Mercer, has resigned as Company Secretary with effect from 31 January 2024. Cathy Baxandall has been appointed Company Secretary with effect from 5 February 2024. Announcement • Dec 13
Doctor Care Anywhere Group plc Appoints Kevin Mercer as Company Secretary Doctor Care Anywhere Group PLC announced that Kevin Mercer, has been appointed as Company Secretary with effect from 12 December 2023, replacing Bianca Foster whose resignation was announced on 1 December 2023. Announcement • Dec 12
Doctor Care Anywhere Group PLC, Annual General Meeting, Jan 04, 2024 Doctor Care Anywhere Group PLC, Annual General Meeting, Jan 04, 2024, at 18:30 AUS Eastern Standard Time. Location: The offices of Crowe U.K. LLP, 55 Ludgate Hill, London,EC4M 7JW London United Kingdom Agenda: To consider and approval authorizing the allotment of Shares and Share Rights in connection with the Convertible Loans; to Approval of the issue of Convertible Notes under the Convertible Note Placement for the purposes of ASX Listing Rule 7.1; to Approval of the issue of Share Options pursuant to the Consultancy Agreement and allotment of Shares on exercise of those Share Options ; to The dis-application of pre-emption rights under s.571 of the Companies Act 2006; and to consider other matters if any. Announcement • Dec 01
Doctor Care Anywhere Group plc Advises Bianca Foster Resigned as Company Secretary Doctor Care Anywhere Group PLC advised that Bianca Foster, has resigned as Company Secretary. Her final day of employment with Doctor Care Anywhere is 30 November 2023. New Risk • Oct 04
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-UK£13m). Share price has been volatile over the past 3 months (12% average weekly change). Market cap is less than US$100m (AU$20.2m market cap, or US$12.8m). Recent Insider Transactions • Sep 06
Independent Non-Executive Chairman recently bought AU$52k worth of stock On the 1st of September, John Stier bought around 1m shares on-market at roughly AU$0.052 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. This was John's only on-market trade for the last 12 months. Reported Earnings • Sep 03
First half 2023 earnings released: UK£0.012 loss per share (vs UK£0.032 loss in 1H 2022) First half 2023 results: UK£0.012 loss per share (improved from UK£0.032 loss in 1H 2022). Revenue: UK£19.2m (up 26% from 1H 2022). Net loss: UK£4.28m (loss narrowed 62% from 1H 2022). Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Healthcare Services industry in Australia. Announcement • Jul 06
Doctor Care Anywhere Group PLC Appoints Aleksandra Spencer (Ola) as an Independent Non-Executive Director Doctor Care Anywhere Group PLC announced the appointment of Dr. Aleksandra Spencer (Ola) as an independent non-executive director. Dr. Spencer's appointment is effective 03 July 2023, and she will also assume responsibility for chairing the company's audit and risk management committee. Dr. Spencer brings extensive experience in healthcare and life sciences, digital transformation and innovation as well as organisational governance. She is a member of the Chartered Institute of Management Accountants and holds a PHD in Novel therapies for Paediatric Cancers and a General Medical Degree. Aleksandra has a successful record of transforming and growing business through innovation. She gained her experience through working with fortune 500 companies, including HCA Healthcare, Pfizer and Merck to reshape their strategies; enabling them to transform into patient/consumer experience driven organizations that engage with the Healthcare Providers, Payers, and Patients in an innovative, secure and compliant way. Aleksandra spent several years with IBM in the technology and business consulting sector advising a wide range of clients on how to transform their businesses to adapt to changing market conditions, improve efficiency, increase competitiveness, and ultimately deliver better value to customers and shareholders. As part of the Executive Team at Optegra International, Aleksandra led a successful business transformation programme during COVID, focused on pathway standardisation and digital transformation; launching virtual consultations, paperless ways of working, shifting strategy from exclusively private towards a mix of private and publicly-funded surgery. This enabled Optegra to be a profitable and sustainable business, more customer-centric yet highly agile, flexible and innovative. Dr. Spencer's experience and background will be invaluable to DCA and will enable to drive its plans for future growth and sustainability forward. Announcement • Jun 06
Connected Medical Solutions Ltd signed a share purchase agreement to acquire GP2U Telehealth Pty Limited from Doctor Care Anywhere Group PLC for AUD 3 million. Connected Medical Solutions Ltd signed a share purchase agreement to acquire GP2U Telehealth Pty Limited from Doctor Care Anywhere Group PLC for AUD 3 million on June 2, 2023. Total consideration of AUD 3 million, comprising AUD 2.5 million worth of unlisted ordinary shares in Connected Medical and AUD 0.5 million of cash, adjusted for normalized working capital. The transaction is subject to the satisfaction of certain conditions, including MED shareholder approval. Completion is expected to occur by the end of June 2023. Breakeven Date Change • Mar 26
Forecast to breakeven in 2024 The analyst covering Doctor Care Anywhere Group expects the company to break even for the first time. New forecast suggests losses will reduce by 45% to 2023. The company is expected to make a profit of UK£400.0k in 2024. Average annual earnings growth of 96% is required to achieve expected profit on schedule. Reported Earnings • Feb 28
Full year 2022 earnings released: UK£0.06 loss per share (vs UK£0.063 loss in FY 2021) Full year 2022 results: UK£0.06 loss per share. Revenue: UK£29.8m (up 19% from FY 2021). Net loss: UK£22.0m (loss widened 9.0% from FY 2021). Revenue is forecast to grow 30% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Healthcare Services industry in Australia. Announcement • Feb 09
Doctor Care Anywhere Group PLC Announces Interim CEO Changes Doctor Care Anywhere Group PLC announced that Mark Taylor has stepped down as Interim Chief Executive Officer of Doctor Care Anywhere due to ill health. Ben Kent has been appointed and will act as Interim Chief Executive Officer in his place. Ben has worked in the health sector for the past 18 years, in the UK and internationally, for Bupa and Simplyhealth, and was Chief Operating Officer and Chief Financial Officer of Doctor Care Anywhere in 2020-21, working on DCA's listing on the ASX. Ben has extensive experience of leading businesses in digital health, health insurance and health services, in Europe, the Middle East, Asia and Australia, and has lived and worked in the UK, Australia and North America. Board Change • Nov 16
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Non-Executive Director David Ravech is the most experienced director on the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Announcement • Sep 19
Doctor Care Anywhere Group plc Appointst Bianca Foster as Company Secretary Doctor Care Anywhere Group PLC advised that Bianca Foster has been appointed as a Company Secretary. Major Estimate Revision • Sep 04
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast fell from UK£36.4m to UK£30.7m. EPS estimate reaffirmed at -UK£0.04 per share. Healthcare Services industry in Australia expected to see average net income growth of 29% next year. Consensus price target down from AU$0.35 to AU$0.12. Share price fell 17% to AU$0.10 over the past week. Reported Earnings • Aug 30
First half 2022 earnings released: UK£0.03 loss per share (vs UK£0.025 loss in 1H 2021) First half 2022 results: UK£0.03 loss per share (down from UK£0.025 loss in 1H 2021). Revenue: UK£15.4m (up 37% from 1H 2021). Net loss: UK£11.6m (loss widened 44% from 1H 2021). Over the next year, revenue is forecast to grow 28%, compared to a 37% growth forecast for the Healthcare Services industry in Australia. Breakeven Date Change • Aug 29
No longer forecast to breakeven The 2 analysts covering Doctor Care Anywhere Group no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of UK£4.20m in 2024. New consensus forecast suggests the company will make a loss of UK£9.90m in 2024. Announcement • Aug 25
Doctor Care Anywhere Says It Got Several Expressions of Interest from Parties Doctor Care Anywhere Group PLC (ASX:DOC) has received several high-level expressions of interest from parties. There is no ongoing discussions relating to a takeover or other change of control of co at this time. The current cash reserves are expected to sustain its operations until First Quarter of 2023. The company will seek to secure additional funding to support company's ongoing operations and growth. Board Change • Jul 14
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director John Stier was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Board Change • Jun 01
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Non-Executive Director John Stier was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Announcement • May 17
Doctor Care Anywhere Group PLC, Annual General Meeting, Jun 08, 2022 Doctor Care Anywhere Group PLC, Annual General Meeting, Jun 08, 2022, at 17:00 E. Australia Standard Time. Agenda: To consider and approve financial statements and reports, adoption of remuneration report; to consider reappointment of auditors; to consider election of directors; and to consider such other matters. Announcement • May 08
Doctor Care Anywhere Group plc Appoints John Stier as an Independent Non-Executive Director Doctor Care Anywhere Group PLC announce the appointment of John Stier as an independent Non-Executive Director. John will also Chair the Company's Audit and Risk Management Committee. John is currently a Board member and Chair of the Audit and Risk Committee at Redburn, a stockbroking firm based in London. John's appointment is effective immediately and is a further step towards a fully independent Board as previously announced. Announcement • Apr 21
Doctor Care Anywhere Group PLC Reaffirms Financial Guidance for the Fiscal Year 2022 Doctor Care Anywhere Group PLC reaffirmed financial guidance for the fiscal year 2022. Revenue in fiscal year 2022 is expected to be at least £35 million to £38 million (AUD 66 million to AUD 71 million), representing 40%-50% growth above fiscal year 2021. Announcement • Apr 19
Doctor Care Anywhere Group PLC Announces Executive Changes Doctor Care Anywhere Group PLC announced the first step in its plan to move to a fully independent Board. Mr. Jonathan Baines, Executive Chairman, has retired, and Dr. Richard Dammery, currently Independent Chairman of the Company's Audit and Risk Management Committee, has been appointed by the Board as interim Chairman. Announcement • Apr 14
Doctor Care Anywhere Group PLC to Report Q1, 2022 Results on Apr 21, 2022 Doctor Care Anywhere Group PLC announced that they will report Q1, 2022 results on Apr 21, 2022 Recent Insider Transactions • Apr 08
Insider recently bought AU$636k worth of stock On the 4th of April, Alexander Waislitz bought around 2m shares on-market at roughly AU$0.38 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$759k more in shares than they have sold in the last 12 months. Reported Earnings • Apr 04
Full year 2021 earnings: EPS misses analyst expectations Full year 2021 results: UK£0.06 loss per share (up from UK£0.18 loss in FY 2020). Revenue: UK£25.0m (up 116% from FY 2020). Net loss: UK£20.2m (loss narrowed 35% from FY 2020). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 5.3%. Over the next year, revenue is forecast to grow 45%, compared to a 98% growth forecast for the industry in Australia. Major Estimate Revision • Mar 14
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast increased from UK£34.9m to UK£36.0m. Forecast EPS reduced from -UK£0.03 to -UK£0.05 per share. Healthcare Services industry in Australia expected to see average net income growth of 26% next year. Consensus price target of AU$1.29 unchanged from last update. Share price fell 5.1% to AU$0.28 over the past week. Recent Insider Transactions • Mar 04
Independent Non-Executive Director recently bought AU$104k worth of stock On the 28th of February, Vanessa Wallace bought around 205k shares on-market at roughly AU$0.51 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Breakeven Date Change • Mar 01
Forecast to breakeven in 2023 The 2 analysts covering Doctor Care Anywhere Group expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 47% to 2022. The company is expected to make a profit of UK£700.0k in 2023. Average annual earnings growth of 99% is required to achieve expected profit on schedule. Announcement • Feb 28
Doctor Care Anywhere Group PLC Provides Revenue Guidance for the Fiscal Year 2022 and for the End of First Half of 2023 Doctor Care Anywhere Group PLC provided revenue guidance for the fiscal year 2022 and for the end of first half of 2023. Revenue in fiscal year 2022 is expected to be at least £35-38 million (AUD 66-71 million), representing 40-50% growth above fiscal year 2021.For the end of first half of 2023, the company expects revenue of annualised run-rate of between £45-55 million (AUD 85-104 million). Announcement • Feb 19
Doctor Care Anywhere Group PLC to Report Fiscal Year 2021 Results on Feb 23, 2022 Doctor Care Anywhere Group PLC announced that they will report fiscal year 2021 results on Feb 23, 2022 Announcement • Dec 16
Doctor Care Anywhere Group plc Announces Launch of New Operating Model Doctor Care Anywhere Group PLC announced the launch of a new Operating Model. Doctor Care Anywhere's Operating Model is evolving from the provision of a single option of 20 minute virtual GP consultations to the provision of multiple options based on a patient's clinical requirement, including: A 15 or 20 minute virtual GP consultation; A 20 minute virtual consultation with an Advanced Nurse Practitioner; and "QuickConsult" - where a patient completes a questionnaire to be reviewed by a prescribing clinician, resulting in written advice or a prescription without the need for a real time video or phone consultation. This new Operating Model will allow Doctor Care Anywhere to better meet the challenge of clinical workforce shortages and ever increasing healthcare demand, resulting in: Improved access to the right care, at the right time, for a larger number of patients; A better experience for clinicians, by matching the right skills with the right presenting patient need; and Significant improvement in the margins and profitability of Doctor Care Anywhere's service. Announcement • Sep 09
Doctor Care Anywhere Group PLC (ASX:DOC) acquired GP2U Telehealth Pty Ltd for AUD 11 million. Doctor Care Anywhere Group PLC (ASX:DOC) acquired GP2U Telehealth Pty Ltd for AUD 11 million on September 9, 2021. AUD 3.3 million will be settled in cash on completion of the transaction, funded by DOC’s existing cash reserves, the equivalent of AUD 7.7 million settled in DOC CDIs, subject to 12 months escrow. A total of 10,555,173
CDIs were issued to shareholders of GP2U Telehealth at a price of AUD 0.73 per CDI. GP2U"s revenue for the year ended 2021 was 0.0013 million while the EBITA lies at 0.0001 million. Aurenda Partners acted as the sole corporate, strategic and M&A advisor to Doctor Care Anywhere, alongside Herbert Smith Freehills as legal counsel and PwC as financial due diligence advisor.
Doctor Care Anywhere Group PLC (ASX:DOC) completed the acquisition of GP2U Telehealth Pty Ltd on September 9, 2021. Reported Earnings • Aug 22
First half 2021 earnings released: UK£0.025 loss per share (vs UK£0.095 loss in 1H 2020) The company reported a solid first half result with reduced losses, improved revenues and improved control over expenses. First half 2021 results: Revenue: UK£11.2m (up 146% from 1H 2020). Net loss: UK£8.04m (loss narrowed 57% from 1H 2020). Breakeven Date Change • Jul 28
No longer forecast to breakeven The 2 analysts covering Doctor Care Anywhere Group no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of UK£200.0k in 2023. New consensus forecast suggests the company will make a loss of UK£100.0k in 2023. Announcement • Apr 27
Doctor Care Anywhere Group PLC Provides earnings Guidance for 2021 Doctor Care Anywhere Group PLC announced that it is confident that it will deliver at least 100% year-on-year revenue growth in Fiscal Year 2021. Reported Earnings • Apr 02
Full year 2020 earnings released: UK£0.18 loss per share (vs UK£0.048 loss in FY 2019) The company reported a decent full year result with improved revenues, although losses increased and control over costs was weaker. Full year 2020 results: Revenue: UK£11.6m (up 102% from FY 2019). Net loss: UK£31.3m (loss widened 451% from FY 2019). Is New 90 Day High Low • Mar 11
New 90-day low: AU$1.00 The company is down 7.0% from its price of AU$1.08 on 11 December 2020. The Australian market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 22% over the same period. Reported Earnings • Mar 01
Full year 2020 earnings released: UK£0.18 loss per share (vs UK£0.29 loss in FY 2019) The company reported a decent full year result with improved revenues, although losses increased and control over costs was weaker. Full year 2020 results: Revenue: UK£11.6m (up 102% from FY 2019). Net loss: UK£31.3m (loss widened 451% from FY 2019). Analyst Estimate Surprise Post Earnings • Mar 01
Earnings beat expectations, revenue disappoints Revenue missed analyst estimates by 0.2%. Earnings per share (EPS) exceeded analyst estimates by 151%. Over the next year, revenue is forecast to grow 87%, compared to a 47% growth forecast for the Healthcare Services industry in Australia. 
